Former United States Securities and Exchange Commission attorney
and the securities litigation firm of
Powers Taylor, LLP
are investigating the sale of DUSA Pharmaceuticals, Inc. (“DUSA”) (Nasdaq GM: DUSA) to Sun Pharmaceuticals Industries Limited for shareholders. Under the proposed deal valued at approximately $230 million, DUSA shareholders will only receive $8.00 in cash for each share of DUSA stock owned, well below at least one analyst’s estimated value of $9.50 per share.
If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at
, or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at
. There is no cost or fee to you.
The DUSA sale investigation centers on whether DUSA’s shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues DUSA’s stock, and whether DUSA’s board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. According to an analyst with Yahoo! Finance, the true inherent value of DUSA could be as high as $9.50 per share, well above the proposed price of $8.00. Shareholder rights attorney Willie Briscoe stated that, “due in part to analysts’ estimates, we believe that this transaction may undervalue DUSA’s stock. Our proposed lawsuit will seek to obtain the highest share price for all shareholders.”
The Briscoe Law Firm, PLLC
is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
Powers Taylor, LLP
is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.